Literature DB >> 33513399

High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma.

Marutpong Detarya1, Salak Thaenkaew2, Wunchana Seubwai3, Somsiri Indramanee1, Chatchai Phoomak1, Charupong Saengboonmee4, Sopit Wongkham4, Chaisiri Wongkham5.   

Abstract

AIMS: Epidemiological studies indicate diabetes mellitus and hyperglycemia as risk factors of cancers including cholangiocarcinoma (CCA). How high glucose promotes cancer development and progression, however, is still unrevealed. In this study, insight into the molecular pathway of high glucose promoting progression of CCA cells was investigated. MAIN
METHODS: Human CCA cell lines, KKU-213A and KKU-213B were cultured in normal glucose (NG; 5.56 mM) or high glucose (HG; 25 mM) and used as NG and HG cells. Forkhead box M1 (FOXM1) expression was transiently suppressed using siFOXM1. Western blotting and image analysis were employed to semi-quantitatively determine the expression levels of the specified proteins. The migration and invasion of CCA cells were revealed using Boyden chamber assays. KEY
FINDINGS: All HG cells exhibited higher expression of FOXM1 than the corresponding NG cells in a dose dependent manner. Suppression of FOXM1 expression by siFOXM1 significantly reduced migration and invasion abilities of CCA cells by suppression of Slug and MMP2 expression. Inhibition of STAT3 activation using Stattic, significantly suppressed expression of FOXM1 and Slug and decreased migration and invasion abilities of HG cells. In addition, EGFR expression was significantly higher in HG cells than NG cells and increased dependently with glucose concentration. Inhibition of EGFR activation by cetuximab significantly suppressed STAT3 activation and FOXM1 expression. SIGNIFICANCE: The mechanism of high glucose promoting progression of CCA cells was revealed to be via in part by upregulation of FOXM1 expression under EGF/EGFR and STAT3 dependent activation.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggressiveness 3 or more not in the title; Bile duct cancer; Biliary tract carcinoma; EGFR; FOXM1; Forkhead box M1; Migration; STAT3

Year:  2021        PMID: 33513399     DOI: 10.1016/j.lfs.2021.119114

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight.

Authors:  Marutpong Detarya; Worachart Lert-Itthiporn; Panupong Mahalapbutr; Methus Klaewkla; Supannika Sorin; Kanlayanee Sawanyawisuth; Atit Silsirivanit; Wunchana Seubwai; Chaisiri Wongkham; Norie Araki; Sopit Wongkham
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

2.  Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression.

Authors:  Kun Wang; Xiaoyong Dai; Albert Yu; Chunyan Feng; Kewei Liu; Laiqiang Huang
Journal:  J Exp Clin Cancer Res       Date:  2022-09-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.